Selected research
Market Structure
Global Histone Methyltransferases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Histone Methyltransferases market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Histone Methyltransferases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Histone Methyltransferases include Eisai Co., Ltd., Pfizer, Glaxosmithkline (Gsk), Sirtris, Sigma-Aldrich, Sequenom, Inc., Ribomed Biotechnologies, Inc., Reaction Biology Corp. and Rana Therapeutics Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Histone Methyltransferases market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Histone Methyltransferases and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Histone Methyltransferases sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Histone Methyltransferases market size, projected growth trends, production technologies, key applications, and end-use industries.
Histone Methyltransferases Segment by Company
Eisai Co., Ltd.
Pfizer
Glaxosmithkline (Gsk)
Sirtris
Sigma-Aldrich
Sequenom, Inc.
Ribomed Biotechnologies, Inc.
Reaction Biology Corp.
Rana Therapeutics Inc.
Prognosdx Health, Inc.
Pharmacyclics, Inc
Epizyme, Inc.
Epitherapeutics APS
Domainex
Constellation Pharmaceuticals
Cellcentric Ltd.
Histone Methyltransferases Segment by Type
EZ
RIZ
SET1
SET2
SMYD
SUV39
SUV4-20
Histone Methyltransferases Segment by Application
Breast Cancer
Liver Cancer
Lung Cancer
Others
Histone Methyltransferases Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Methyltransferases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Histone Methyltransferases and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Methyltransferases.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Histone Methyltransferases market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Histone Methyltransferases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Histone Methyltransferases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Histone Methyltransferases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- EZ
- RIZ
- SET1
- SET2
- SMYD
- SUV39
- SUV4-20
Applications
- Breast Cancer
- Liver Cancer
- Lung Cancer
- Others
Companies covered
- Eisai Co., Ltd.
- Pfizer
- Glaxosmithkline (Gsk)
- Sirtris
- Sigma-Aldrich
- Sequenom, Inc.
- Ribomed Biotechnologies, Inc.
- Reaction Biology Corp.
- Rana Therapeutics Inc.
- Prognosdx Health, Inc.
- Pharmacyclics, Inc
- Epizyme, Inc.
- Epitherapeutics APS
- Domainex
- Constellation Pharmaceuticals
- Cellcentric Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Histone Methyltransferases Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Histone Methyltransferases Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Histone Methyltransferases Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Histone Methyltransferases Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Histone Methyltransferases Market Dynamics
- 2.1 Histone Methyltransferases Industry Trends
- 2.2 Histone Methyltransferases Industry Drivers
- 2.3 Histone Methyltransferases Industry Opportunities and Challenges
- 2.4 Histone Methyltransferases Industry Restraints
3 Histone Methyltransferases Market by Manufacturers
- 3.1 Global Histone Methyltransferases Revenue by Manufacturers (2021-2026)
- 3.2 Global Histone Methyltransferases Sales by Manufacturers (2021-2026)
- 3.3 Global Histone Methyltransferases Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Histone Methyltransferases Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Histone Methyltransferases Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Histone Methyltransferases Manufacturers, Product Type & Application
- 3.7 Global Histone Methyltransferases Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Histone Methyltransferases Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Histone Methyltransferases Players Market Share by Revenue in 2025
- 3.8.3 2025 Histone Methyltransferases Tier 1, Tier 2, and Tier 3
4 Histone Methyltransferases Market by Type
- 4.1 Histone Methyltransferases Type Introduction
- 4.1.1 EZ
- 4.1.2 RIZ
- 4.1.3 SET1
- 4.1.4 SET2
- 4.1.5 SMYD
- 4.1.6 SUV39
- 4.1.7 SUV4-20
- 4.2 Global Histone Methyltransferases Sales by Type
- 4.2.1 Global Histone Methyltransferases Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Histone Methyltransferases Sales by Type (2021-2032)
- 4.2.3 Global Histone Methyltransferases Sales Market Share by Type (2021-2032)
- 4.3 Global Histone Methyltransferases Revenue by Type
- 4.3.1 Global Histone Methyltransferases Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Histone Methyltransferases Revenue by Type (2021-2032)
- 4.3.3 Global Histone Methyltransferases Revenue Market Share by Type (2021-2032)
5 Histone Methyltransferases Market by Application
- 5.1 Histone Methyltransferases Application Introduction
- 5.1.1 Breast Cancer
- 5.1.2 Liver Cancer
- 5.1.3 Lung Cancer
- 5.1.4 Others
- 5.2 Global Histone Methyltransferases Sales by Application
- 5.2.1 Global Histone Methyltransferases Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Histone Methyltransferases Sales by Application (2021-2032)
- 5.2.3 Global Histone Methyltransferases Sales Market Share by Application (2021-2032)
- 5.3 Global Histone Methyltransferases Revenue by Application
- 5.3.1 Global Histone Methyltransferases Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Histone Methyltransferases Revenue by Application (2021-2032)
- 5.3.3 Global Histone Methyltransferases Revenue Market Share by Application (2021-2032)
6 Global Histone Methyltransferases Sales by Region
- 6.1 Global Histone Methyltransferases Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Histone Methyltransferases Sales by Region (2021-2032)
- 6.2.1 Global Histone Methyltransferases Sales by Region (2021-2026)
- 6.2.2 Global Histone Methyltransferases Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Histone Methyltransferases Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Histone Methyltransferases Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Histone Methyltransferases Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Histone Methyltransferases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Histone Methyltransferases Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Histone Methyltransferases Revenue by Region
- 7.1 Global Histone Methyltransferases Revenue by Region
- 7.1.1 Global Histone Methyltransferases Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Histone Methyltransferases Revenue by Region (2021-2026)
- 7.1.3 Global Histone Methyltransferases Revenue by Region (2027-2032)
- 7.1.4 Global Histone Methyltransferases Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Histone Methyltransferases Revenue (2021-2032)
- 7.2.2 North America Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Histone Methyltransferases Revenue (2021-2032)
- 7.3.2 Europe Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Histone Methyltransferases Revenue (2021-2032)
- 7.4.2 Asia-Pacific Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Histone Methyltransferases Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Histone Methyltransferases Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Eisai Co., Ltd.
- 8.1.1 Eisai Co., Ltd. Company Information
- 8.1.2 Eisai Co., Ltd. Business Overview
- 8.1.3 Eisai Co., Ltd. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Eisai Co., Ltd. Histone Methyltransferases Product Portfolio
- 8.1.5 Eisai Co., Ltd. Recent Developments
- 8.2 Pfizer
- 8.2.1 Pfizer Company Information
- 8.2.2 Pfizer Business Overview
- 8.2.3 Pfizer Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Pfizer Histone Methyltransferases Product Portfolio
- 8.2.5 Pfizer Recent Developments
- 8.3 Glaxosmithkline (Gsk)
- 8.3.1 Glaxosmithkline (Gsk) Company Information
- 8.3.2 Glaxosmithkline (Gsk) Business Overview
- 8.3.3 Glaxosmithkline (Gsk) Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Glaxosmithkline (Gsk) Histone Methyltransferases Product Portfolio
- 8.3.5 Glaxosmithkline (Gsk) Recent Developments
- 8.4 Sirtris
- 8.4.1 Sirtris Company Information
- 8.4.2 Sirtris Business Overview
- 8.4.3 Sirtris Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Sirtris Histone Methyltransferases Product Portfolio
- 8.4.5 Sirtris Recent Developments
- 8.5 Sigma-Aldrich
- 8.5.1 Sigma-Aldrich Company Information
- 8.5.2 Sigma-Aldrich Business Overview
- 8.5.3 Sigma-Aldrich Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sigma-Aldrich Histone Methyltransferases Product Portfolio
- 8.5.5 Sigma-Aldrich Recent Developments
- 8.6 Sequenom, Inc.
- 8.6.1 Sequenom, Inc. Company Information
- 8.6.2 Sequenom, Inc. Business Overview
- 8.6.3 Sequenom, Inc. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Sequenom, Inc. Histone Methyltransferases Product Portfolio
- 8.6.5 Sequenom, Inc. Recent Developments
- 8.7 Ribomed Biotechnologies, Inc.
- 8.7.1 Ribomed Biotechnologies, Inc. Company Information
- 8.7.2 Ribomed Biotechnologies, Inc. Business Overview
- 8.7.3 Ribomed Biotechnologies, Inc. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Ribomed Biotechnologies, Inc. Histone Methyltransferases Product Portfolio
- 8.7.5 Ribomed Biotechnologies, Inc. Recent Developments
- 8.8 Reaction Biology Corp.
- 8.8.1 Reaction Biology Corp. Company Information
- 8.8.2 Reaction Biology Corp. Business Overview
- 8.8.3 Reaction Biology Corp. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Reaction Biology Corp. Histone Methyltransferases Product Portfolio
- 8.8.5 Reaction Biology Corp. Recent Developments
- 8.9 Rana Therapeutics Inc.
- 8.9.1 Rana Therapeutics Inc. Company Information
- 8.9.2 Rana Therapeutics Inc. Business Overview
- 8.9.3 Rana Therapeutics Inc. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Rana Therapeutics Inc. Histone Methyltransferases Product Portfolio
- 8.9.5 Rana Therapeutics Inc. Recent Developments
- 8.10 Prognosdx Health, Inc.
- 8.10.1 Prognosdx Health, Inc. Company Information
- 8.10.2 Prognosdx Health, Inc. Business Overview
- 8.10.3 Prognosdx Health, Inc. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Prognosdx Health, Inc. Histone Methyltransferases Product Portfolio
- 8.10.5 Prognosdx Health, Inc. Recent Developments
- 8.11 Pharmacyclics, Inc
- 8.11.1 Pharmacyclics, Inc Company Information
- 8.11.2 Pharmacyclics, Inc Business Overview
- 8.11.3 Pharmacyclics, Inc Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Pharmacyclics, Inc Histone Methyltransferases Product Portfolio
- 8.11.5 Pharmacyclics, Inc Recent Developments
- 8.12 Epizyme, Inc.
- 8.12.1 Epizyme, Inc. Company Information
- 8.12.2 Epizyme, Inc. Business Overview
- 8.12.3 Epizyme, Inc. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Epizyme, Inc. Histone Methyltransferases Product Portfolio
- 8.12.5 Epizyme, Inc. Recent Developments
- 8.13 Epitherapeutics APS
- 8.13.1 Epitherapeutics APS Company Information
- 8.13.2 Epitherapeutics APS Business Overview
- 8.13.3 Epitherapeutics APS Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Epitherapeutics APS Histone Methyltransferases Product Portfolio
- 8.13.5 Epitherapeutics APS Recent Developments
- 8.14 Domainex
- 8.14.1 Domainex Company Information
- 8.14.2 Domainex Business Overview
- 8.14.3 Domainex Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Domainex Histone Methyltransferases Product Portfolio
- 8.14.5 Domainex Recent Developments
- 8.15 Constellation Pharmaceuticals
- 8.15.1 Constellation Pharmaceuticals Company Information
- 8.15.2 Constellation Pharmaceuticals Business Overview
- 8.15.3 Constellation Pharmaceuticals Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Constellation Pharmaceuticals Histone Methyltransferases Product Portfolio
- 8.15.5 Constellation Pharmaceuticals Recent Developments
- 8.16 Cellcentric Ltd.
- 8.16.1 Cellcentric Ltd. Company Information
- 8.16.2 Cellcentric Ltd. Business Overview
- 8.16.3 Cellcentric Ltd. Histone Methyltransferases Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Cellcentric Ltd. Histone Methyltransferases Product Portfolio
- 8.16.5 Cellcentric Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Histone Methyltransferases Value Chain Analysis
- 9.1.1 Histone Methyltransferases Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Histone Methyltransferases Production Mode & Process
- 9.2 Histone Methyltransferases Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Histone Methyltransferases Distributors
- 9.2.3 Histone Methyltransferases Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst